Home
About
News
Education
Research
Research Ethics
Ways to Help
Contact Us
Shop
More
JPII Research Institute
Dr. Moy Presentation to Davenport Medical Society Part 1
Genetic and Rare Disease Research Program
Dr. Moy Presentation to Davenport Medical Society Part 2
Cutting Edge Cancer Technology
Dr. Moy Presentation to Davenport Medical Society Part 3
Dr. Moy Presentation to Davenport Medical Society Part 4
Dr. Moy Presentation to Davenport Medical Society Part 5
Dr. Moy Presentation to Davenport Medical Society Part 6
EWTN Live - 2015.2.4 - Alan Moy - John Paul II Medical Research Institute
JP2MRI Cancer Session 1
Live Action: "No One Knows When Life Begins"
JP2MRI Campaign for Cures-New Ethical Human Cell Lines
May 5, 2020 - Church Militant Exclusive Interview with Dr. Alan Moy
JP2MRI COVID-19 Vaccine Introduction
JP2MRI Research Overview
Addressing Ethical and Scientific Shortcomings of "Operation Warp Speed"
JP2MRI Ethical and Cutting-Edge COVID-19 Vaccine Research
Dr. Alan Moy and Ethical Research - Episode 59 from The St. Philip Institute Podcast
Dr. Alan Moy Catholic Citizens Luncheon, Chicago, IL, 4-16-21
Alan Moy M.D., vice president of the John Paul II Medical Research Institute, on COVID segregation, Chicago's Morning Answer, 7-15-21
Alan Moy M.D. on Chicago's Morning Answer about COVID vaccines and vaccine mandates, 9-13-21
JP2MRI Oct 2021 COVID-19 Vaccine Research Update
Vaccine Mandates Won't Stop COVID-19 & How to Advance Biotechnology Without Morally-Illicit Cells
The Future Crisis to Catholics From Secular Biotechnology-What Is the Scale of the Problem?
The Unrecognized Crisis to Catholics From Secular Biotechnology-Launching a Pro-Life Biotech Sector
The Future Crisis to Catholics From Secular Biotechnology-Solving the Embryonic Stem Cell Dilemma
JP2MRI Creates Ethical Human Stem Cells to Replace HEK293
How Does JP2MRI Compare with Secular Medical Research Organizations?
Iowa Board of Medicine Decision Against Alan Moy, MD
Alan Moy M.D. Discusses the Misinformation Accusations Against Him on Chicago's Morning Answer
